Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Current Leases (2011 - 2026)

Palatin Technologies' (PTN) quarterly Current Leases came in at $189205.0 in Q1 2026, down 2.96% on a YoY basis from $194972.0 in Q1 2025, and down 13.89% quarter-over-quarter from $219727.0 in Q4 2025.

Analysis

Palatin Technologies (PTN) Current Leases (2011 - 2026) Analysis & Trends

Palatin Technologies (PTN) has reported Current Leases for 13 consecutive years, with $189205.0 the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Current Leases fell 2.96% year-over-year to $189205.0; the trailing twelve-month figure through Mar 2026 stood at $189205.0 (down 2.96% YoY), and the FY2025 full-year result was $129812.0, down 65.89% from the prior year.
  • Current Leases eased to $189205.0 in Q1 2026 per PTN's latest filing, from $219727.0 in the prior quarter.
  • Across five years, Current Leases topped out at $380542.0 in Q2 2024 and bottomed at $129812.0 in Q2 2025.
  • Historically, Current Leases has averaged $291714.5 across 5 years, with a median of $326947.0 in 2023.
  • The sharpest annual moves came in 2024 and 2025: Current Leases increased 23.28% in 2024, then plunged 65.89% in 2025.
  • Over 5 years, Current Leases stood at $335732.0 in 2022, then grew by 8.34% to $363718.0 in 2023, then retreated by 29.16% to $257673.0 in 2024, then slipped by 14.73% to $219727.0 in 2025, then fell by 13.89% to $189205.0 in 2026.
  • According to Business Quant data, Current Leases over the past three periods registered $189205.0, $219727.0, and $132446.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 720.00 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 11.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 45.93 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 12.38 Mn
10 Palatin Technologies 46.98 Mn 46.98 Mn - 189,205.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 189,205.00
Dec 31, 2025 219,727.00
Sep 30, 2025 132,446.00
Jun 30, 2025 129,812.00
Mar 31, 2025 194,972.00
Dec 31, 2024 257,673.00
Sep 30, 2024 319,520.00
Jun 30, 2024 380,542.00
Mar 31, 2024 371,280.00
Dec 31, 2023 363,718.00
Sep 30, 2023 326,947.00
Jun 30, 2023 354,052.00
Mar 31, 2023 301,169.00
Dec 31, 2022 335,732.00
Sep 30, 2022 343,749.00
Jun 30, 2022 371,124.00
Mar 31, 2022 367,478.00
Dec 31, 2021 360,655.00
Sep 30, 2021 353,925.00
Jun 30, 2021 351,853.00